SANTEN PHARMACEUTICAL CO revenue for the last year amounted to 33.06 B MXN, the most of which — 30.77 B MXN — came from its highest performing source at the moment, Prescription Drugs, the year earlier bringing 35.33 B MXN. The greatest contribution to the revenue figure was made by Japan — last year it brought SANTEN PHARMACEUTICAL CO 19.23 B MXN, and the year before that — 24.08 B MXN.